Pelvic disorder treatment device
23 Assignments
0 Petitions
Accused Products
Abstract
A device (20) for treating a medical condition is provided, and a surgical procedure for implanting the device is disclosed. The device (20) includes a sensor (44), which is adapted to generate a signal responsive to a state of a patient, and at least one electrode (27), which is adapted to be coupled to a pelvic site of the patient. A control unit (22) is adapted to receive the signal, to analyze the signal so as to distinguish between an imminent stress incontinence event and an imminent urge event, and, responsive to analyzing the signal, to apply an electrical waveform to the at least one electrode (27). In various configurations, the device (20) may be used alternatively or additionally to treat fecal incontinence, interstitial cystitis, chronic pelvic pain, or urine retention.
-
Citations
224 Claims
-
1-179. -179. (canceled)
-
180. A device, comprising:
-
at least one electrode, which is adapted to be coupled to a pelvic muscle of a patient; and
a control unit, which is adapted to drive the at least one electrode to apply to the muscle an electrical waveform configured to treat a neurogenic bladder condition of the patient. - View Dependent Claims (182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196)
-
-
181. A device, comprising:
-
at least one electrode, which is adapted to be coupled to a pelvic muscle of a patient; and
a control unit, which is adapted to drive the at least one electrode to apply to the muscle an electrical waveform configured to treat an urgency frequency symptom of the patient. - View Dependent Claims (198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212)
-
-
197. A method for implanting a medical device in a patient, comprising:
-
creating a suprapubic incision in the patient;
creating a vaginal mucosa incision in the patient;
passing between the two incisions an electrode lead which is adapted for coupling to the medical device; and
implanting the medical device in the patient, wherein implanting the device comprises implanting a device which is capable of treating a neurogenic bladder condition of the patient.
-
-
213. A device, comprising:
-
a sensor, which is adapted to generate a signal responsive to a state of a patient;
at least one electrode, which is adapted to be coupled to a pelvic site of the patient; and
a control unit, which is adapted to receive the signal, to analyze the signal so as to distinguish between an imminent stress incontinence event and an imminent urge event, and, responsive to analyzing the signal, to apply an electrical waveform to the at least one electrode, wherein the control unit is adapted to configure the waveform so as to induce relaxation of a bladder muscle responsive to analyzing the signal and determining that an urge event is imminent, and wherein the control unit is adapted to configure the waveform to have a duty cycle between about 6% and about 50%.
-
-
214. A device, comprising:
-
a sensor, which is adapted to generate a signal responsive to a state of a patient;
at least one electrode, which is adapted to be coupled to a pelvic site of the patient; and
a control unit, which is adapted to receive the signal, to analyze the signal so as to distinguish between an imminent stress incontinence event and an imminent urge event, and, responsive to analyzing the signal, to apply an electrical waveform to the at least one electrode, wherein the control unit is adapted to configure the waveform so as to induce relaxation of a bladder muscle responsive to analyzing the signal and determining that an urge event is imminent, and wherein the control unit is adapted to configure the waveform to have a duty cycle of between about 2 and about 10 seconds on, and between about 10 and about 30 seconds off.
-
-
215. A device, comprising:
-
at least one electrode, which is adapted to be coupled to a pelvic muscle of a patient; and
a control unit, which is adapted to drive the at least one electrode to apply to the muscle an electrical waveform configured to reduce patient pain due to interstitial cystitis, wherein the control unit is adapted to configure the waveform so as to induce relaxation of a bladder muscle of the patient, and wherein the control unit is adapted to configure the waveform to have a duty cycle between about 6% and about 50%.
-
-
216. A device, comprising:
-
at least one electrode, which is adapted to be coupled to a pelvic muscle of a patient; and
a control unit, which is adapted to drive the at least one electrode to apply to the muscle an electrical waveform configured to reduce patient pain due to interstitial cystitis, wherein the control unit is adapted to configure the waveform so as to induce relaxation of a bladder muscle of the patient, and wherein the control unit is adapted to configure the waveform to have a duty cycle of between about 2 and about 10 seconds on, and between about 10 and about 30 seconds off.
-
-
217. A device, comprising:
-
a sensor, which is adapted to generate a signal responsive to a state of a patient;
at least one electrode, which is adapted to be coupled to an anatomical site of the patient; and
a control unit, which is adapted to receive the signal, to analyze the signal so as to determine a likelihood of imminent patient pain due to interstitial cystitis, and, responsive to analyzing the signal, to apply to the at least one electrode an electrical waveform configured to reduce patient pain due to interstitial cystitis, wherein the control unit is adapted to configure the waveform to have a duty cycle between about 6% and about 50%.
-
-
218. A device, comprising:
-
a sensor, which is adapted to generate a signal responsive to a state of a patient;
at least one electrode, which is adapted to be coupled to an anatomical site of the patient; and
a control unit, which is adapted to receive the signal, to analyze the signal so as to determine a likelihood of imminent patient pain due to interstitial cystitis, and, responsive to analyzing the signal, to apply to the at least one electrode an electrical waveform configured to reduce patient pain due to interstitial cystitis, wherein the control unit is adapted to configure the waveform to have a duty cycle of between about 2 and about 10 seconds on, and between about 10 and about 30 seconds off.
-
-
219. A device, comprising:
-
at least one electrode, which is adapted to be coupled to a pelvic muscle of a patient; and
a control unit, which is adapted to drive the at least one electrode to apply to the muscle an electrical waveform configured to reduce patient pelvic pain, wherein the control unit is adapted to configure the waveform to have a duty cycle between about 6% and about 50%.
-
-
220. A device, comprising:
-
at least one electrode, which is adapted to be coupled to a pelvic muscle of a patient; and
a control unit, which is adapted to drive the at least one electrode to apply to the muscle an electrical waveform configured to reduce patient pelvic pain, wherein the control unit is adapted to configure the waveform to have a duty cycle of between about 2 and about 10 seconds on, and between about 10 and about 30 seconds off.
-
-
221. A device, comprising:
-
a sensor, which is adapted to generate a signal responsive to a state of a patient;
at least one electrode, which is adapted to be coupled to an anatomical site of the patient; and
a control unit, which is adapted to receive the signal, to analyze the signal so as to determine a likelihood of patient pelvic pain, and, responsive to analyzing the signal, to apply to the at least one electrode an electrical waveform configured to reduce the patient pelvic pain, wherein the control unit is adapted to configure the waveform to have a duty cycle between about 6% and about 50%.
-
-
222. A device, comprising:
-
a sensor, which is adapted to generate a signal responsive to a state of a patient;
at least one electrode, which is adapted to be coupled to an anatomical site of the patient; and
a control unit, which is adapted to receive the signal, to analyze the signal so as to determine a likelihood of patient pelvic pain, and, responsive to analyzing the signal, to apply to the at least one electrode an electrical waveform configured to reduce the patient pelvic pain, wherein the control unit is adapted to configure the waveform to have a duty cycle of between about 2 and about 10 seconds on, and between about 10 and about 30 seconds off.
-
-
223. A device, comprising:
-
at least one electrode, which is adapted to be implanted at a pelvic muscle site of a patient; and
a control unit, which is adapted to drive the at least one electrode to apply to the muscle an electrical waveform configured to inhibit urine retention of the patient, wherein the control unit is adapted to configure the waveform to have a duty cycle between about 6% and about 50%.
-
-
224. A device, comprising:
-
at least one electrode, which is adapted to be implanted at a pelvic muscle site of a patient; and
a control unit, which is adapted to drive the at least one electrode to apply to the muscle an electrical waveform configured to inhibit urine retention of the patient, wherein the control unit is adapted to configure the waveform to have a duty cycle of between about 2 and about 10 seconds on, and between about 10 and about 30 seconds off.
-
Specification